中文产业新闻评分65Chinese source
Tinlarebant治疗STGD1的上市申请获FDA优先审评
眼科药物资讯｜STGD1首款新药上市申请获FDA优先审评：以视黄醇底物削减延缓视网膜萎缩
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
眼科药物资讯｜STGD1首款新药上市申请获FDA优先审评：以视黄醇底物削减延缓视网膜萎缩
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.